Adult-Onset Type 1 Diabetes Development Following COVID-19 mRNA Vaccination (Moon et al.): 56-year-old female patient developed hyperglycemia after second dose of COVID-19 mRNA-based vaccination

SOURCE:
https://pubmed.ncbi.nlm.nih.gov/36625174/
‘visited our hospital with uncontrolled hyperglycemia despite administration of oral hyperglycemic agents. Her initial glycated hemoglobin level was high (11.0%), and fasting serum C-peptide level was normal. The fasting serum C-peptide level decreased to 0.269 ng/mL 5 days after admission, and the anti-glutamic acid decarboxylase antibody was positive. The patient was discharged in stable condition with insulin treatment.’

Go to Dr Alexancer on Substack
Author: Dr. Paul Alexander